Jones Day’s Fintiv-ITC Developments Tracker, PTAB Litigation Blog
Although first briefly mentioned as a possibility in theAugust 2018 Trial Practice Guide Update(page 10), outside of one instance (Bio-Rad Labs. v. 10X Genomics, IPR2019-00567; -00568, August 8, 2019), PTAB discretionary institution denials under 35 U.S.C. § 314(a) based on ITC proceedings were a non-occurrence. But the expanded discussion of ITC-relevance in theFintiv precedential decision(pages 8-9) has brought on a flurry of Patent Owner Preliminary Response arguments against institution based on parallel ITC matters. And since mid-October 2020, many of those Patent Owner arguments have been successful in getting institution denied.
Jones Day publications should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request reprint permission for any of our publications, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. The mailing of this publication is not intended to create, and receipt of it does not constitute, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.